Optellum, a leader in AI-enabled lung cancer risk assessment, is pleased to announce its selection in a landmark NHS initiative that combines Optellum's AI-driven lung cancer risk stratification with ...
This article is brought to you by our exclusive subscriber partnership with our sister title USA Today, and has been written by our American colleagues. It does not necessarily reflect the view of The ...
England's National Health Service trials of a new artificial intelligence and robotics technology for lung cancer detection ...
The NHS has launched an AI and robot pilot to help spot lung cancer sooner, as well as a screening program that aims to help ...
The company's claimed system benefits included reduced costs from fewer inconclusive or inaccurate diagnostic tests and avoidance of unnecessary staff and procedure costs. It claimed that this would ...